Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.91 USD | -1.51% | -2.15% | -12.84% |
May. 14 | Stephens Initiates Exelixis With Equalweight Rating, $23 Price Target | MT |
May. 10 | Exelixis Files Patent Complaint Against Cipla's Cancer Treatment | DJ |
- Stock Market
- Equities
- EXEL Stock
- Charts Exelixis, Inc.
- Static Chart